series-b
Stage
3
Investors
About
BioInvent is a clinical-stage biotech company that discovers and develops novel immunomodulatory antibodies for cancer therapy, utilizing its proprietary F.I.R.S.T™ technology platform to identify both targets and antibodies for its clinical pipeline.
Explore BioInvent's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.